Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
About this item
Full title
Author / Creator
Sweeney, Christopher J , Chen, Yu-Hui , Carducci, Michael , Liu, Glenn , Jarrard, David F , Eisenberger, Mario , Wong, Yu-Ning , Hahn, Noah , Kohli, Manish , Cooney, Matthew M , Dreicer, Robert , Vogelzang, Nicholas J , Picus, Joel , Shevrin, Daniel , Hussain, Maha , Garcia, Jorge A and DiPaola, Robert S
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this trial, the addition of six cycles of docetaxel to androgen-deprivation therapy resulted in longer median progression-free and overall survival than that with ADT alone in patients with metastatic prostate cancer.
Regressions of metastatic prostate cancer were first documented in the 1940s and were achieved with surgical castration; subse...
Alternative Titles
Full title
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4562797
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4562797
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1503747
